2-Amino-7-substituted benzoxazole analogs as potent RSK2 inhibitors.
Costales, A., Mathur, M., Ramurthy, S., Lan, J., Subramanian, S., Jain, R., Atallah, G., Setti, L., Lindvall, M., Appleton, B.A., Ornelas, E., Feucht, P., Warne, B., Doyle, L., Basham, S.E., Aronchik, I., Jefferson, A.B., Shafer, C.M.(2014) Bioorg Med Chem Lett 24: 1592-1596
- PubMed: 24534486 
- DOI: https://doi.org/10.1016/j.bmcl.2014.01.058
- Primary Citation of Related Structures:  
4NW5, 4NW6 - PubMed Abstract: 
2-Amino-7-substituted benzoxazole analogs were identified by HTS as inhibitors of RSK2. Molecular modeling and medicinal chemistry techniques were employed to explore the SAR for this series with a focus of improving in vitro and target modulation potency and physicochemical properties.
Organizational Affiliation: 
Global Discovery Chemistry/Oncology & Exploratory Chemistry, Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, CA 94608, USA. Electronic address: cynthia.shafer@novartis.com.